Scientific Research Grants

Scientific Research Grants is sponsored by Florida Breast Cancer Foundation. One-year grants for basic, clinical, translational breast cancer research, environmental factors, and epidemiological studies in Florida.

Scientific Research Grants 2027 Request for Scientific Grant Applications Proposals Now Being Accepted Thanks to the support of Floridians in purchasing the End Breast Cancer specialty license plate as well as the Florida Breast Cancer Foundation’s network of breast cancer supporters, survivors, and activists fighting to end breast cancer, we have invested over $15M to fulfill our goal of dedicated funding for education and research programs in the state of Florida.

The Florida Breast Cancer Foundation (FBCF), along with those who generously support us with their talent, time, and resources, is working to better the lives of those facing breast cancer in Florida. Grants are awarded in support of innovative education and research programs throughout the state.

The Florida Breast Cancer Foundation is currently offering scientific grants for Pilot Program research projects, with a maximum of $100,000 for a one-year project. Preference will be given to new/first-time applicants, as well as to research applications that demonstrate a collaborative and integrated multidisciplinary approach. The committee reserves the right to place limitations on awards.

Innovative projects may include basic, clinical, and translational breast cancer research; novel epidemiological studies of breast cancer; research on possible links between breast cancer and the environment; and psycho-immunological research. Letter of Intent Deadline is December 11, 2026, 5:00 pm February 12, 2027, 5:00 pm Basic, clinical (including novel diagnostic/therapeutic modalities), and translational breast cancer research.

Understanding the links between environmental factors and breast cancer in Florida. Novel epidemiological studies to provide insight into opportunities for improving breast cancer outcomes in Florida. Psycho-immunologic mechanisms and breast cancer progression: implications for improving outcomes.

Innovative awards and idea grants All applications must cover at least one of the priority areas.

2027 Special Emphasis Areas: Vulnerable and/or at-risk populations Comorbidities and treatment-related adverse side effects Genetic screening and risk assessment The Florida Breast Cancer Foundation supports unique research projects or ideas (from small- to large-scale) that specifically focus on scientific and clinical breast cancer issues, which, if successfully addressed, could ultimately revolutionize the understanding, diagnosis, and/or treatment of breast cancer and move us closer to the goal of eradicating the disease.

The critical components of this award mechanism are as follows: Impact: The most important aspect of the grant is the proposed research's potential to have a radical, revolutionary impact on an area of paramount importance in breast cancer. The potential impact may be near-term or long-term, but it must be transformative.

It is the responsibility of the applicant to clearly and explicitly articulate the potential impact on breast cancer, including how it would be transformative. Research Question: Research proposed under the grant must address an underexplored issue of critical significance in breast cancer.

The FBCF particularly encourages applications that focus on less explored or poorly understood areas that are of high importance in breast cancer, such as those related to prevention, susceptibility, protection, recurrence, and metastasis. The proposed work must be based on a sound overall research strategy and may be from any discipline or combination of disciplines.

New Investigators and multi-disciplinary research teams: New investigators are considered to be in the first three years of a tenure-track position, or an equivalent independent research appointment, at their institution.

Multi-disciplinary research teams can include investigators at all levels but should involve expertise from at least two different disciplines, such as a basic cancer biologist teamed with a medical oncologist or a chemist.

Guidelines and Instructions for Applicants Letter of Intent (LOI) due Announcement of Grant Award Recipients Only Florida-based non-profit community-based organizations that are tax-exempt under Internal Revenue Code section 501(c)(3), Florida governmental entities, Florida-based tax-exempt educational institutions, and Indian tribes within the State of Florida are eligible to apply for funding.

Organizations registered as 501(c)(3) entities outside of Florida are eligible to apply if a physical presence is maintained within the state of Florida that is open and fully operating for 12 months a year. All activities funded through this competition must occur in Florida. All work must occur, and all funds must be spent in Florida at the applicant organization and any collaborating entities within Florida.

Applications must be submitted in English. Applicants must ensure that all past and current FBCF grants or awards are up-to-date and in compliance with FBCF’s contract and reporting requirements. If the organization has an open Scientific award with FBCF, the award must be current and due to be completed by the end of the grant period to be eligible to apply for the new grant cycle.

Research must be conducted in the State of Florida. Funds will be limited to $100,000 for 1 year, including a maximum of 20% for indirect costs. Patient care costs and equipment costs are exempt from indirect costs (IDCs) calculations.

When calculating salaries, use the most current NIH cap. LOI must be submitted by the due date. Grants that do not submit an LOI will not be accepted.

Note that submission of an LOI is non-binding.

If the applicant or any of its key employees, directors, officers, or agents are convicted of fraud or any crime involving other financial or administrative impropriety within the preceding 12 months, the applicant is not eligible to apply for a grant during the current funding cycle, and will not be eligible to apply for a new grant until the applicant can demonstrate that appropriate remedial measures have been implemented to mitigate any criminal conduct occurring in the future.

The LOI MUST be submitted in electronic form in ProposalCentral and received no later than December 11, 2026 by 5:00 pm The grant application must be submitted in electronic form in ProposalCentral and received no later than February 12, 2027 Please contact Jessica Parker-Kerr directly for any questions regarding the application at: Jessica@FloridaBreastCancer. org . Instructions for ProposalCentral.

com 1) To start an application , go to the ProposalCentral website by clicking the pink button above, APPLY HERE. NEW USERS: If you are a new user to ProposalCentral, follow the Need an Account? link and complete the registration process.

PREVIOUSLY REGISTERED USERS: If you are already a registered user, login at proposalcentral. com with your username and password. If you have forgotten your password, click Forgot your Password?

link. 2) Once you are logged in , please click the Professional Profile tab at the top and complete steps 1-10 or update with current information. Information on several of the pages (Project Director and Organization/Institution) in the Application will be pulled from the Professional Profile.

3) To start an application , select the Grant Opportunities tab and a list of applications will be displayed. Find Florida Breast Cancer Foundation and click the Apply Now link next to the Direct Services Grant to create your Application. If you have any technical issues, please contact ProposalCentral at pcsupport@altum.

com . 2026-2027 Scientific Research Grant Recipients H. Lee Moffitt Cancer Center & Research Institute, Inc – Dr. Martina Molgora Impact of Obesity on Macrophage-Targeting Strategies in Breast Cancer H.

Lee Moffitt Cancer Center & Research Institute, Inc – Dr. Thordur Oskarsson Mapping tetraspanin webs that control chemoresistance in dormant breast cancer H.

Lee Moffitt Cancer Center & Research Institute, Inc – Dr. Vural Tagal Coordinated Therapeutic Strikes along the Ploidy Axis Mayo Clinic Jacksonville – Dr. Saranya Chumsri AI-Enabled Spatial Single-Cell Immune Mapping in Triple-Negative Breast Cancer University of Central Florida Board of Trustees – Dr. Wencai Zhang Metabolic Targeting of SDH to Block Metastasis in Triple-Negative Breast Cancer University of Florida – Dr. Thomas Burris The use of ERR agonists to prevent Doxorubicin-induced Heart Failure University of Florida – Dr. Rodrigo Cristofoletti Smart Trop-2 CAR-T with Synthetic Circuits for TNBC Precision University of Florida – Dr. Sulma Mohammed Silent Highways: Targeting the Lymphatic Network to Halt Breast Cancer Metastasis University of Florida – Dr. Weizhou Zhang FOXA1 in lobular breast cancer - Biology and Therapeutic Target University of Miami – Dr. Xiaodong Cai Accurate and cost-effective AI prognostic models for breast cancer LEARN MORE ABOUT THE 2026-2027 SCIENTIFIC RESEARCH GRANTS 2025-2026 Scientific Research Grant Recipients 2023-2024 Scientific Research Grant Recipients 2022-2023 Scientific Research Grant Recipients 2021-2022 Scientific Research Grant Recipients 2019-2020 Scientific Research Grant Recipients 2018-2019 Scientific Research Grant Recipients 2016-2018 Scientific Research Grant Recipients 2014-2016 Scientific Research Grant Recipients 2012-2013 Scientific Research Grant Recipients 2009-2011 Scientific Research Grant Recipients 2008-2009 Scientific Research Grant Recipients 2006-2007 Scientific Research Grant Recipients 2005-2006 Scientific Research Grant Recipients 2004-2005 Scientific Research Grant Recipients